AbbVie (NYSE: ABBV)
AbbVie Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
AbbVie Company Info
AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology, oncology, including blood cancers, virology, hepatitis C virus (HCV) and human immunodeficiency virus (HIV), neurological disorders, such as Parkinson's, metabolic, comprising thyroid disease and complications associated with cystic fibrosis, pain associated with endometriosis, and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL.
News & Analysis
Is AbbVie a Millionaire Maker?
Everything is going according to plan, and more growth is on the way.
9 Best Index Funds for Long-Term Investors
Here are the nine best index funds to add to your portfolio for steady, low-cost growth.
3 Dividend Growth Stocks With Yields Above 3% That You Can Buy and Hold for the Next Decade
Income-seeking investors can look forward to steady payout raises from these pharma stocks.
3 No-Brainer Dividend Stocks to Buy in April
Income investors will find a lot to like about these stocks.
Investing in Blue Chip ETFs
An in-depth look at the leading blue chip stock ETFs in the U.S stock market this year.
Got $3,000? 2 Monster Growth Stocks to Buy Right Now Without Hesitation
These stocks can deliver powerhouse portfolio growth in the years ahead.
2 Top Dividend Stocks to Buy Hand Over Fist
Every company faces headwinds eventually. The top ones know how to bounce back.
Have $2,500? 2 Superior Growth Stocks to Buy in 2024
These businesses can pack a punch in your portfolio over the long run.
Valuation
Earnings Transcripts
AbbVie (ABBV) Q4 2023 Earnings Call Transcript
ABBV earnings call for the period ending December 31, 2023.
AbbVie (ABBV) Q3 2023 Earnings Call Transcript
ABBV earnings call for the period ending September 30, 2023.
AbbVie (ABBV) Q2 2023 Earnings Call Transcript
ABBV earnings call for the period ending June 30, 2023.
AbbVie (ABBV) Q1 2023 Earnings Call Transcript
ABBV earnings call for the period ending March 31, 2023.
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.